Based on this, the combined blocking of ODC and eukaryotic translation initiation factor 5A (eIF5A) can effectively inhibit c-MYC and produce a synergistic anti-tumor effect in CRC (Coni et al., 2023). The gene discussed is EIF5A; the disease is colorectal carcinoma.